US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist

0.2267
-0.0108-4.55%

Close Jun 14 16:00 ET

0.2379
+0.0112+4.94%

Post 17:54 ET

1.89MMarket Cap-419P/E (TTM)

InMed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Mar 31, 2024

(Q2)Dec 31, 2023

(Q1)Sep 30, 2023

(FY)Jun 30, 2023

(Q4)Jun 30, 2023

(Q3)Mar 31, 2023

(Q2)Dec 31, 2022

(Q1)Sep 30, 2022

(FY)Jun 30, 2022

(Q4)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-16.76%-1.93M

31.88%-1.85M

3.61%-2.17M

53.26%-7.28M

83.74%-657.93K

69.03%-1.66M

23.22%-2.71M

15.01%-2.26M

-59.17%-15.58M

-101.75%-4.05M

Net income from continuing operations

13.77%-1.72M

29.65%-1.48M

27.73%-2.54M

57.27%-7.95M

95.70%-338.39K

42.52%-2M

50.94%-2.1M

-18.12%-3.51M

-82.30%-18.6M

-141.50%-7.87M

Operating gains losses

5,717.24%1.63K

-65.34%-1.04K

-27.83%2.02K

-90.99%1.18K

-165.50%-955

96.01%-29

-105.65%-629

121.55%2.8K

105.41%13.13K

114.10%1.46K

Depreciation and amortization

1.02%150.69K

3.56%152.61K

0.58%149.36K

16.45%596K

-2.00%150.97K

-2.71%149.16K

-1.74%147.36K

172.80%148.51K

123.79%511.79K

221.92%154.06K

Other non cash items

-1,069.23%-252

-61.41%-481

-348.33%-538

-100.06%-803

-100.03%-411

--26

---298

99.31%-120

423.05%1.39M

5,180.07%1.39M

Change In working capital

-395.36%-418.82K

16.90%-709.77K

-77.16%93.65K

81.59%-565.82K

80.85%-263.48K

106.39%141.8K

-340.14%-854.16K

143.64%410.02K

-582.23%-3.07M

-236.16%-1.38M

-Change in receivables

286.33%165.19K

-126.09%-207.02K

29.77%94.55K

-447.76%-219.15K

-539.79%-111.79K

-337.79%-88.65K

-14,451.57%-91.56K

2,592.58%72.86K

-199.53%-40.01K

-129.93%-17.47K

-Change in inventory

-258.38%-449.11K

31.98%217.78K

187.94%390.33K

128.23%565.56K

98.26%-18.59K

165.71%283.58K

132.89%165.02K

--135.56K

---2M

---1.07M

-Change in prepaid assets

-28.42%94.29K

-90.95%-897.96K

-35.76%283.02K

56.92%299.19K

-61.66%197.17K

111.25%131.73K

-320.82%-470.27K

-30.56%440.56K

123.16%190.66K

39.09%514.31K

-Change in payables and accrued expense

-36.45%-104.34K

169.04%241.38K

-253.19%-562.48K

0.62%-806.53K

64.12%-221.19K

84.44%-76.47K

-145.66%-349.61K

66.06%-159.26K

-334.10%-811.6K

-205.82%-616.47K

-Change in other current assets

--0

--1.79K

-43.38%3.12K

108.96%5.51K

--0

-8.67%5.51K

-333.81%-61.43K

---68.01K

-Change in other current liabilities

11.24%-96.19K

12.76%-94.4K

2.17%-98.71K

-24.78%-426.58K

0.13%-109.09K

-0.81%-108.38K

---108.21K

---100.9K

---341.86K

---109.23K

-Change in other working capital

---28.66K

5,984.08%28.66K

-203.00%-16.17K

414.49%16.17K

--0

--471

--15.7K

---5.14K

---8.9K

Cash from discontinued investing activities

Operating cash flow

-16.76%-1.93M

31.88%-1.85M

3.61%-2.17M

53.26%-7.28M

83.74%-657.93K

69.03%-1.66M

23.22%-2.71M

15.01%-2.26M

-59.17%-15.58M

-101.75%-4.05M

Investing cash flow

Cash flow from continuing investing activities

100.00%-2

98.14%-9.29K

1.66%-661.8K

95.37%-33.61K

-3,508.16%-128.2K

-263.39%-500K

-38,914.43%-673K

-41,955.48%-725.46K

Net PPE purchase and sale

100.00%-2

----

-313.74%-161.8K

---33.61K

-3,508.16%-128.2K

----

-2,167.13%-39.11K

--0

Net business purchase and sale

--0

----

-139.36%-500K

--0

----

---208.89K

---300.46K

Net investment purchase and sale

--0

----

Net other investing changes

----

---425K

----

Cash from discontinued investing activities

Investing cash flow

100.00%-2

98.14%-9.29K

--0

1.66%-661.8K

95.37%-33.61K

-3,508.16%-128.2K

-263.39%-500K

--0

-38,914.43%-673K

-41,955.48%-725.46K

Financing cash flow

Cash flow from continuing financing activities

-12.44%4.65M

-29.13%10.68M

-117.31%-63.7K

735.69%5.32M

-50.12%5.43M

38.84%15.07M

6,172.97%5.05M

Net issuance payments of debt

----

--0

----

---290.83K

--395.69K

Net common stock issuance

--0

-1.90%4.65M

--0

-30.01%12M

-74.35%1.32M

---63.7K

2,695,346.59%4.74M

-50.00%6M

37.47%17.15M

--5.15M

Net other financing activities

----

26.05%-1.32M

----

48.77%-571.26K

-10.32%-1.78M

-489.77%-490.54K

Cash from discontinued financing activities

Financing cash flow

--0

-12.44%4.65M

--0

-29.13%10.68M

--0

-117.31%-63.7K

735.69%5.32M

-50.12%5.43M

38.84%15.07M

6,172.97%5.05M

Net cash flow

Beginning cash position

-16.74%9.53M

-27.94%6.74M

44.29%8.91M

-16.11%6.18M

62.83%9.6M

1.53%11.45M

-39.06%9.35M

-16.11%6.18M

26.82%7.36M

-37.61%5.9M

Current changes in cash

-4.64%-1.93M

33.04%2.8M

-168.51%-2.17M

330.61%2.74M

-348.26%-691.54K

65.65%-1.85M

151.73%2.1M

-60.23%3.17M

-211.66%-1.19M

113.32%278.55K

End cash Position

-20.86%7.6M

-16.74%9.53M

-27.94%6.74M

44.29%8.91M

62.83%9.6M

1.53%11.45M

-39.06%9.35M

-16.11%6.18M

Free cash flow

-8.38%-1.93M

31.54%-1.86M

3.61%-2.17M

52.35%-7.45M

82.91%-691.54K

66.65%-1.78M

23.99%-2.71M

15.01%-2.26M

-59.54%-15.62M

-101.58%-4.05M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Mar 31, 2024	(Q2)Dec 31, 2023	(Q1)Sep 30, 2023	(FY)Jun 30, 2023	(Q4)Jun 30, 2023	(Q3)Mar 31, 2023	(Q2)Dec 31, 2022	(Q1)Sep 30, 2022	(FY)Jun 30, 2022	(Q4)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-16.76%-1.93M	31.88%-1.85M	3.61%-2.17M	53.26%-7.28M	83.74%-657.93K	69.03%-1.66M	23.22%-2.71M	15.01%-2.26M	-59.17%-15.58M	-101.75%-4.05M
Net income from continuing operations	13.77%-1.72M	29.65%-1.48M	27.73%-2.54M	57.27%-7.95M	95.70%-338.39K	42.52%-2M	50.94%-2.1M	-18.12%-3.51M	-82.30%-18.6M	-141.50%-7.87M
Operating gains losses	5,717.24%1.63K	-65.34%-1.04K	-27.83%2.02K	-90.99%1.18K	-165.50%-955	96.01%-29	-105.65%-629	121.55%2.8K	105.41%13.13K	114.10%1.46K
Depreciation and amortization	1.02%150.69K	3.56%152.61K	0.58%149.36K	16.45%596K	-2.00%150.97K	-2.71%149.16K	-1.74%147.36K	172.80%148.51K	123.79%511.79K	221.92%154.06K
Other non cash items	-1,069.23%-252	-61.41%-481	-348.33%-538	-100.06%-803	-100.03%-411	--26	---298	99.31%-120	423.05%1.39M	5,180.07%1.39M
Change In working capital	-395.36%-418.82K	16.90%-709.77K	-77.16%93.65K	81.59%-565.82K	80.85%-263.48K	106.39%141.8K	-340.14%-854.16K	143.64%410.02K	-582.23%-3.07M	-236.16%-1.38M
-Change in receivables	286.33%165.19K	-126.09%-207.02K	29.77%94.55K	-447.76%-219.15K	-539.79%-111.79K	-337.79%-88.65K	-14,451.57%-91.56K	2,592.58%72.86K	-199.53%-40.01K	-129.93%-17.47K
-Change in inventory	-258.38%-449.11K	31.98%217.78K	187.94%390.33K	128.23%565.56K	98.26%-18.59K	165.71%283.58K	132.89%165.02K	--135.56K	---2M	---1.07M
-Change in prepaid assets	-28.42%94.29K	-90.95%-897.96K	-35.76%283.02K	56.92%299.19K	-61.66%197.17K	111.25%131.73K	-320.82%-470.27K	-30.56%440.56K	123.16%190.66K	39.09%514.31K
-Change in payables and accrued expense	-36.45%-104.34K	169.04%241.38K	-253.19%-562.48K	0.62%-806.53K	64.12%-221.19K	84.44%-76.47K	-145.66%-349.61K	66.06%-159.26K	-334.10%-811.6K	-205.82%-616.47K
-Change in other current assets	--0	--1.79K	-43.38%3.12K	108.96%5.51K	--0	--0	--0	-8.67%5.51K	-333.81%-61.43K	---68.01K
-Change in other current liabilities	11.24%-96.19K	12.76%-94.4K	2.17%-98.71K	-24.78%-426.58K	0.13%-109.09K	-0.81%-108.38K	---108.21K	---100.9K	---341.86K	---109.23K
-Change in other working capital	---28.66K	5,984.08%28.66K	-203.00%-16.17K	414.49%16.17K	--0	--0	--471	--15.7K	---5.14K	---8.9K
Cash from discontinued investing activities
Operating cash flow	-16.76%-1.93M	31.88%-1.85M	3.61%-2.17M	53.26%-7.28M	83.74%-657.93K	69.03%-1.66M	23.22%-2.71M	15.01%-2.26M	-59.17%-15.58M	-101.75%-4.05M
Investing cash flow
Cash flow from continuing investing activities	100.00%-2	98.14%-9.29K	0	1.66%-661.8K	95.37%-33.61K	-3,508.16%-128.2K	-263.39%-500K	0	-38,914.43%-673K	-41,955.48%-725.46K
Net PPE purchase and sale	100.00%-2	----	----	-313.74%-161.8K	---33.61K	-3,508.16%-128.2K	----	----	-2,167.13%-39.11K	--0
Net business purchase and sale	--0	----	----	-139.36%-500K	--0	--0	----	----	---208.89K	---300.46K
Net investment purchase and sale	--0	--0	--0	--0	--0	--0	--0	--0	--0	----
Net other investing changes	----	----	----	----	----	----	----	----	---425K	----
Cash from discontinued investing activities
Investing cash flow	100.00%-2	98.14%-9.29K	--0	1.66%-661.8K	95.37%-33.61K	-3,508.16%-128.2K	-263.39%-500K	--0	-38,914.43%-673K	-41,955.48%-725.46K
Financing cash flow
Cash flow from continuing financing activities	0	-12.44%4.65M	0	-29.13%10.68M	0	-117.31%-63.7K	735.69%5.32M	-50.12%5.43M	38.84%15.07M	6,172.97%5.05M
Net issuance payments of debt	----	----	----	--0	----	----	----	----	---290.83K	--395.69K
Net common stock issuance	--0	-1.90%4.65M	--0	-30.01%12M	-74.35%1.32M	---63.7K	2,695,346.59%4.74M	-50.00%6M	37.47%17.15M	--5.15M
Net other financing activities	----	----	----	26.05%-1.32M	----	----	----	48.77%-571.26K	-10.32%-1.78M	-489.77%-490.54K
Cash from discontinued financing activities
Financing cash flow	--0	-12.44%4.65M	--0	-29.13%10.68M	--0	-117.31%-63.7K	735.69%5.32M	-50.12%5.43M	38.84%15.07M	6,172.97%5.05M
Net cash flow
Beginning cash position	-16.74%9.53M	-27.94%6.74M	44.29%8.91M	-16.11%6.18M	62.83%9.6M	1.53%11.45M	-39.06%9.35M	-16.11%6.18M	26.82%7.36M	-37.61%5.9M
Current changes in cash	-4.64%-1.93M	33.04%2.8M	-168.51%-2.17M	330.61%2.74M	-348.26%-691.54K	65.65%-1.85M	151.73%2.1M	-60.23%3.17M	-211.66%-1.19M	113.32%278.55K
End cash Position	-20.86%7.6M	-16.74%9.53M	-27.94%6.74M	44.29%8.91M	44.29%8.91M	62.83%9.6M	1.53%11.45M	-39.06%9.35M	-16.11%6.18M	-16.11%6.18M
Free cash flow	-8.38%-1.93M	31.54%-1.86M	3.61%-2.17M	52.35%-7.45M	82.91%-691.54K	66.65%-1.78M	23.99%-2.71M	15.01%-2.26M	-59.54%-15.62M	-101.58%-4.05M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall